Sellas Life Sciences Group Inc
(SLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,041 | -8,568 | -4,143 | -19,292 | -11,873 |
| Income taxes - deferred | N/A | N/A | N/A | -95 | N/A |
| Accounts payable and accrued liabilities | -2,123 | -1,476 | -1,303 | 12 | -227 |
| Other Working Capital | -1,578 | -2,221 | -2,936 | -1,112 | -1,422 |
| Other Operating Activity | 2,901 | 2,053 | 1,551 | 2,844 | 55 |
| Operating Cash Flow | $-13,841 | $-10,212 | $-6,831 | $-17,643 | $-13,467 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,459 | 5,967 | 5,988 | 19,569 | 17,250 |
| Other Financing Activity | 308 | 308 | 312 | 0 | 0 |
| Financing Cash Flow | $14,767 | $6,275 | $6,300 | $19,569 | $17,250 |
| Beginning Cash Position | 7,377 | 7,377 | 7,377 | 5,451 | 5,451 |
| End Cash Position | 8,303 | 3,440 | 6,846 | 7,377 | 9,234 |
| Net Cash Flow | $926 | $-3,937 | $-531 | $1,926 | $3,783 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,841 | -10,212 | -6,831 | -17,643 | -13,467 |
| Free Cash Flow | -13,841 | -10,212 | -6,831 | -17,643 | -13,467 |